CSIMarket
 
Allergan plc  (AGN)
Other Ticker:  
 
 
 

Allergan Plc's vs. its Competitors Results

(List of Competitors, Financial Results for the last period ending MRQ, in Millions of $)



COMPANY NAME TICKER REVENUE NET INCOME NET MARGIN CASH FLOW
Allergan plc 1 Q 2020 AGN 3,604.40 379.00 10.51 % -1,503.80
Merck and Co Inc 3 Q 2023 MRK 15,962.00 4,750.00 29.76 % 2,957.00
Pfizer Inc 4 Q 2023 PFE 14,248.00 -3,360.00 - -316.00
Johnson and Johnson 4 Q 2023 JNJ 13,532.00 4,049.00 29.92 % 2,131.00
Amgen Inc 4 Q 2023 AMGN 8,196.00 767.00 9.36 % -23,797.00
Teva Pharmaceutical Industries Limited 4 Q 2023 TEVA 4,456.00 433.00 9.72 % 977.00
Est e Lauder Companies Inc 4 Q 2024 EL 4,279.00 324.00 7.57 % 849.00
Biogen Inc 4 Q 2023 BIIB 2,386.30 248.90 10.43 % -1,285.90
Enact Holdings Inc 4 Q 2023 ACT 296.19 157.31 53.11 % -62.31
Agile Therapeutics Inc 4 Q 2023 AGRX 3.42 -4.47 - -0.32
Jubilant Flame International Ltd 4 Q 2024 JFIL 0.00 -0.01 - 0.00
APROX. MARKET 1 Q SUBTOTAL 66,963.31 7,743.73 11.56 % -18,547.52






Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com